Evidence map›Paper›PMID 41025245›Full record

ArticleJournal of microbiology (Seoul, Korea)2025

Efficient CRISPR-based genome editing for inducible degron systems to enable temporal control of protein function in large double-stranded DNA virus genomes.

Kihye Shin, Eui Tae Kim

Abstract read
In one paragraph

Article in Journal of microbiology (Seoul, Korea), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kihye ShinDepartment of Microbiology and Immunology, Jeju National University College of Medicine, Jeju 63241, Republic of Korea.
Eui Tae KimDepartment of Microbiology and Immunology, Jeju National University College of Medicine, Jeju 63241, Republic of Korea.

Funding

Korea Health Industry Development InstituteMinistry of Education RS-2023-00270936Ministry of Health and Welfare RS-2022-KH129726Ministry of Health and Welfare RS-2024-00438990Ministry of Science and ICT RS-2024-00352590
6 · The paper itself

Abstract

CRISPR-Cas9-based gene editing enables precise genetic modifications. However, its application to human cytomegalovirus (HCMV) remains challenging due to the large size of the viral genome and the essential roles of key regulatory genes. Here, we establish an optimized CRISPR-Cas9 system for precise labeling and functional analysis of HCMV immediate early (IE) genes. By integrating a multifunctional cassette encoding an auxin-inducible degron (AID), a self-cleaving peptide (P2A), and GFP into the viral genome via homology-directed repair (HDR), we achieved efficient knock-ins without reliance on bacterial artificial chromosome (BAC) cloning, a labor-intensive and time-consuming approach. We optimized delivery strategies, donor template designs, and component ratios to enhance HDR efficiency, significantly improving knock-in success rates. This system enables real-time fluorescent tracking and inducible protein degradation, allowing temporal control of essential viral proteins through auxin-mediated depletion. Our approach provides a powerful tool for dissecting the dynamic roles of viral proteins throughout the HCMV life cycle, facilitating a deeper understanding of viral pathogenesis and potential therapeutic targets.

Indexed as

CRISPR-Cas SystemsCytomegalovirusGene EditingGenome, ViralViral ProteinsDegronsGreen Fluorescent ProteinsHumansIndoleacetic AcidsRecombinational DNA RepairGreen Fluorescent ProteinsIndoleacetic AcidsViral Proteinsauxin-inducible degron (AID) systemCRISPR-Cas9 genome editinghuman cytomegalovirus (HCMV)integrase-deficient lentivirus (IDLV)

Identifiers

PMID41025245
PMCPMC13577094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.